Rapport Therapeutics to participate in upcoming investor conferences
Rapport Therapeutics says it will participate in upcoming investor conferences, a clinical-stage biotech focused on small molecule precision medicines.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.